Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 4/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7666396 | 0.90 | ALDH1A1 (0.49) | ALDH1A1ALOX15KDM4EHSD17B10NPC1 | |
| SCHEMBL31074983 | 0.88 | NPC1 (0.53) | ALDH1A1CTSDCNR2KDM4EHSD17B10 | |
| SCHEMBL5011915 | 0.88 | ALDH1A1 (0.47) | ALDH1A1ALOX15APEX1KDM4EHSD17B10 | |
| SCHEMBL341330 | 0.88 | NPC1 (0.53) | ALDH1A1CTSDCNR2KDM4EHSD17B10 | |
| SCHEMBL29472144 | 0.86 | ALDH1A1 (0.38) | ALDH1A1ALOX15CTSDAPEX1CNR2 | |
| SCHEMBL14431277 | 0.86 | ALDH1A1 (0.47) | ALDH1A1ALOX15CTSDKDM4EHSD17B10 | |
| SCHEMBL1515828 | 0.86 | HSD17B10 (0.43) | ALDH1A1ALOX15CTSDKDM4EHSD17B10 | |
| SCHEMBL24916 | 0.86 | ALDH1A1 (0.57) | ALDH1A1ALOX15KDM4ENPC1RAB9A | |
| SCHEMBL15778308 | 0.86 | ALDH1A1 (0.38) | ALDH1A1ALOX15CTSDAPEX1CNR2 | |
| SCHEMBL29997568 | 0.86 | TDP1 (0.44) | ALDH1A1ALOX15CTSDKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7060332-B2 | Liquid crystal display with alignment film of polyphenylenphthalamide-based material and method for fabricating the same | LG.PHILIPS LCD CO., LTD. (KR) | 2006-06-13 | — | — | US | claimed |
| US-20020182346-A1 | Liquid crystal display with alignment film of polyphenylenphthalamide-based material and method for fabricating the same | LG DISPLAY CO., LTD. (KR) | 2002-12-05 | — | — | US | claimed |
| EP-2051968-B1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | UNIV CALIFORNIA (US) | 2020-04-29 | — | — | EP | disclosed |
| EP-2051968-B1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | UNIV CALIFORNIA (US) | 2020-04-29 | — | — | EP | disclosed |
| EP-3568398-A1 | CRYPTATE DERIVATIVES AND THEIR USE AS LUMINESCENT LANTHANIDE COMPLEXES | Société des Produits Nestlé S.A. (CH) | 2019-11-20 | — | — | EP | disclosed |
| US-20190284211-A1 | CRYPTATES AND METHODS OF USE | NESTEC S.A. (CH) | 2019-09-19 | — | — | US | disclosed |
| US-20190284211-A1 | CRYPTATES AND METHODS OF USE | NESTEC S.A. (CH) | 2019-09-19 | — | — | US | disclosed |
| WO-2018130988-A1 | CRYPTATE DERIVATIVES AND THEIR USE AS LUMINESCENT LANTHANIDE COMPLEXES | NESTEC S.A. (CH) | 2018-07-19 | — | — | WO | disclosed |
| EP-2423201-B1 | Luminescent macrocyclic lanthanide complexes | UNIV CALIFORNIA (US) | 2017-10-04 | — | — | EP | disclosed |
| EP-2423201-B1 | Luminescent macrocyclic lanthanide complexes | UNIV CALIFORNIA (US) | 2017-10-04 | — | — | EP | disclosed |
| US-8729258-B2 | Luminescent macrocyclic lanthanide complexes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-20 | — | — | US | disclosed |
| WO-2008063721-A2 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-05-29 | — | — | WO | disclosed |
| WO-2008063721-A2 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-05-29 | — | — | WO | disclosed |
| US-7060332-B2 | Liquid crystal display with alignment film of polyphenylenphthalamide-based material and method for fabricating the same | LG.PHILIPS LCD CO., LTD. (KR) | 2006-06-13 | — | — | US | disclosed |
| EP-1100486-A4 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-01-15 | — | — | EP | disclosed |
| US-20020182346-A1 | Liquid crystal display with alignment film of polyphenylenphthalamide-based material and method for fabricating the same | LG DISPLAY CO., LTD. (KR) | 2002-12-05 | — | — | US | disclosed |
| EP-1100486-A1 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS | SmithKline Beecham Corporation (US) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000006147-A1 | MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-10 | — | — | WO | disclosed |
| US-4413114-A | FOR FILMS OR FIBERS | TEIJIN LIMITED (JP) | 1983-11-01 | — | — | US | disclosed |
| US-4355151-A | Aromatic copolyamide containing 3,4'-diamino diphenylene moiety | TEIJIN LIMITED (JP) | 1982-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284211-A1 | CRYPTATES AND METHODS OF USE | CA13, KLK3, ALPG | ALDH1A1 598/4885ALOX15 3859/4885CTSD 1996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.